Dr. Dixon on Belinostat Plus CHOP in Patients with T-Cell Lymphoma
In this OncLiveTV video, “Graham Dixon, PhD, chief scientific officer, Onxeo, director, R&D, Onxeo, discusses a phase I study investigating the combination of belinostat (Beleodaq) plus CHOP in patients with ... Read more